Page last updated: 2024-11-04

sulfamethoxypyridazine and Jaundice

sulfamethoxypyridazine has been researched along with Jaundice in 3 studies

Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.

Jaundice: A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
STOCCHI, F1
MASTRILLI, B1
DUNN, PM1
Babior, BM1
Davidson, CS1

Other Studies

3 other studies available for sulfamethoxypyridazine and Jaundice

ArticleYear
[Contribution to the study of jaundice caused by intrahepatic cholestasis of drug origin: forms of chlorpropamide and sulfamethoxypyridazine].
    La Clinica terapeutica, 1962, May-31, Volume: 22

    Topics: Chlorpropamide; Cholestasis, Intrahepatic; Humans; Hypoglycemic Agents; Jaundice; Sulfamethoxypyrida

1962
THE POSSIBLE RELATIONSHIP BETWEEN THE MATERNAL ADMINISTRATION OF SULPHAMETHOXYPYRIDAZINE AND HYPERBILIRUBINAEMIA IN THE NEWBORN.
    The Journal of obstetrics and gynaecology of the British Commonwealth, 1964, Volume: 71

    Topics: Female; Humans; Hyperbilirubinemia; Infant; Infant, Newborn; Jaundice; Jaundice, Neonatal; Maternal-

1964
Hepatitis: drug or viral?
    The American journal of medicine, 1966, Volume: 41, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Halothane; Hepatitis A; Humans; Ipr

1966